• FirefoxUpgrade to the new Firefox »
  •  Dow Up1.69% Nasdaq Up2.12%

    Affymetrix Inc. (AFFX)

    -NasdaqGS
    9.42 Up 0.52(5.84%) 4:00PM EST
    |After Hours : 9.42 0.00 (0.00%) 4:15PM EST
    Add to Portfolio
    ProfileGet Profile for:
    Affymetrix Inc.
    3420 Central Expressway
    Santa Clara, CA 95051
    United States - Map
    Phone: 408-731-5000
    Fax: 408-731-5380
    Website: http://www.affymetrix.com

    Details 
    Index Membership:N/A
    Sector:Technology
    Industry:Scientific & Technical Instruments
    Full Time Employees:1,100

    Business Summary 

    Affymetrix, Inc. provides life science tools and molecular diagnostic products that enable parallel analysis of biological systems at the gene, protein, and cell level primarily in the United States, Europe, Latin America, and Asia. The company operates in two segments, Affymetrix Core and eBioscience. The Affymetrix Core segment is engaged in the development, manufacture, and commercialization of systems for genetic analysis in the life sciences and diagnostic industry. This segment develops and markets GeneChip gene expression products and services; genotyping product line, such as the Axiom product line; arrays and assays with clinical research applications, such as the CytoScan and OncoScan products; QuantiGene line of singleplex and multiplex assays to serve customers in the research and translational medicine markets; and GeneTitan family of products consisting of the GeneTitan instrument system that runs genotyping and gene expression array plates. It also offers life science reagents, such as ExoSAP-IT for a reagent for the clean-up of polymerase chain reaction, and HotStart-IT reagents to inhibit primer dimer formation; enzymes; purification kits; and biochemicals for life science researchers. The eBioscience segment is involved in the development, manufacturing, marketing, and distribution of research products in the areas of flow cytometry, immunoassays, microscopic imaging, and other protein-based analyses. This segment offers a portfolio of antibodies and reagents, as well as a range of the QuantiGene and Procarta assay portfolio. The company sells its products directly and through third party distributors to genomic research centers, academic institutions, government, and private laboratories, as well as pharmaceutical, diagnostic, and biotechnology companies. Affymetrix, Inc. was founded in 1991 and is headquartered in Santa Clara, California.

    Key Statistics


    Company Websites 
    Home Page
    Search Yahoo! for:
    More on Affymetrix Inc.

    Corporate Governance 
    Affymetrix Inc.’s ISS Governance QuickScore as of Dec 1, 2014 is 1. The pillar scores are Audit: 1; Board: 4; Shareholder Rights: 1; Compensation: 3.
    Brought to you by Institutional Shareholder Services (ISS)

    Key Executives 
     PayExercised
    Dr. Stephen P. A. Fodor Ph.D., 60
    Founder, Exec. Chairman and Member of Bus. Review Committee
    112.00K0.00
    Dr. Franklin R. Witney Ph.D., 60
    Chief Exec. Officer, Pres and Director
    761.00K0.00
    Mr. Gavin H. J. Wood , 44
    Chief Financial Officer, Principal Accounting Officer and Exec. VP
    456.00K0.00
    Mr. Andrew J. Last Ph.D., 54
    Chief Operating Officer and Exec. VP
    521.00K0.00
    Mr. David A. Weber , 60
    Chief Commercial Officer and Exec. VP
    460.00K0.00
    Amounts are as of Dec 31, 2013 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
    Currency in USD.
    View Insiders